LLY

1,122.06

-0.63%↓

JNJ

235.31

-0.25%↓

ABBV

222.61

+0.73%↑

UNH

408.57

-0.43%↓

MRK

115.22

+0.3%↑

LLY

1,122.06

-0.63%↓

JNJ

235.31

-0.25%↓

ABBV

222.61

+0.73%↑

UNH

408.57

-0.43%↓

MRK

115.22

+0.3%↑

LLY

1,122.06

-0.63%↓

JNJ

235.31

-0.25%↓

ABBV

222.61

+0.73%↑

UNH

408.57

-0.43%↓

MRK

115.22

+0.3%↑

LLY

1,122.06

-0.63%↓

JNJ

235.31

-0.25%↓

ABBV

222.61

+0.73%↑

UNH

408.57

-0.43%↓

MRK

115.22

+0.3%↑

LLY

1,122.06

-0.63%↓

JNJ

235.31

-0.25%↓

ABBV

222.61

+0.73%↑

UNH

408.57

-0.43%↓

MRK

115.22

+0.3%↑

Search

Smith & Nephew PLC ADR

Atidarymo kaina

30.53 0.16

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

30.42

Max

30.73

Pagrindiniai rodikliai

By Trading Economics

Pajamos

35M

331M

Pardavimai

203M

3.2B

P/E

Sektoriaus vid.

21.217

49.052

Dividendų pajamingumas

2.58

Pelno marža

10.368

Darbuotojai

16,988

EBITDA

133M

856M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+6.11% upside

Dividendai

By Acuity

Dividendų pajamingumas

Sektoriaus vid.

2.58%

2.36%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-2.3B

13B

Ankstesnė atidarymo kaina

30.37

Ankstesnė uždarymo kaina

30.53

Smith & Nephew PLC ADR Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Apie bendrovę Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat